SmallCap Sentinel: Report On Stem Cell Companies Released


IRVINE, Calif., Aug. 20, 2007 (PRIME NEWSWIRE) -- A comprehensive report focusing on Neostem, Inc. (AMEX:NBS) and stem cell related companies has been published by financial courier StockUpTicks.com and is available free of charge to the general public.

The informational report will address preeminent and emerging stem cell companies such as Aastrom Biosciences Inc. (Nasdaq:ASTM), Geron Corp. (Nasdaq:GERN), ViaCell (Nasdaq:VIAC) and Neostem.

The profile is available at the following link: http://stockupticks.com/profiles/8-19-07.html

About NeoStem, Inc.

NeoStem is a biotechnology services company enhancing the delivery of adult stem cell therapeutics. The Company is developing a nationwide network of adult stem cell collection centers, enabling people to donate and store their own stem cells with NeoStem for personal use years or decades later in times of critical medical need.

The proprietary NeoStem technologies empower health-conscious consumers to help protect their future health by undergoing treatment with their own stem-cells - providing an accessible supply of healthy, genetically matched stem cells for use in the eventuality of illness.

Currently underway are hundreds of stem cell-based research programs and clinical trials investigating the use of these non-controversial adult stem cells, such as those collected from donors under NeoStem's methods. As the nation's population ages and encounters serious age-related and congenital health issues, NeoStem has positioned itself as a leader in the fast-growing national trend toward personal "bio-insurance."

For more information, please visit: www.neostem.com.

For other information and resources about the Company, visit www.CFSG1.com or www.trilogy-capital.com/tcp/neostem/quote.html.

*** To have your company featured on StockUpTicks.com or SmallCap Sentinel please use the contact info below. ***

Statements herein contain forward-looking statements and are subject to significant risks and uncertainties affecting results. SmallCap Sentinel/StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience.

All information contained herein is based upon sources believed to be reliable but no representation is made as to accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid fifteen thousand dollars by Trilogy Capital, an investor relations advisor to NeoStem, Inc, for preparation and distribution of this report and other advertising services over a ninety day period. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject company.

The SmallCap Sentinel logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3664



            

Contact Data